Fisher randomization tests for Neyman’s null hypothesis of no average treatment effect are considered in a finite-population setting associated with completely randomized experiments involving more than two treatments. The consequences of using the |F| statistic to conduct such a test are examined, and we argue that under treatment effect heterogeneity, use of the |F| statistic in the Fisher randomization test can severely inflate the Type I error under Neyman’s null hypothesis. We propose to use an alternative test statistic, derive its asymptotic distributions under Fisher’s and Neyman’s null hypotheses, and demonstrate its advantages through simulations.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: